205 related articles for article (PubMed ID: 22897729)
1. Molecular mechanisms of effectiveness of novel therapies in multiple myeloma.
Bianchi G; Ghobrial IM
Leuk Lymphoma; 2013 Feb; 54(2):229-41. PubMed ID: 22897729
[TBL] [Abstract][Full Text] [Related]
2. Contemporary drug therapies for multiple myeloma.
de la Puente P; Azab AK
Drugs Today (Barc); 2013 Sep; 49(9):563-73. PubMed ID: 24086952
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapies in multiple myeloma.
El-Amm J; Tabbara IA
Am J Clin Oncol; 2015 Jun; 38(3):315-21. PubMed ID: 23934133
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma.
Pantani L; Brioli A; Tacchetti P; Zannetti BA; Mancuso K; Rocchi S; Martello M; Rizzello I; Terragna C; Zamagni E; Cavo M
Expert Rev Hematol; 2016 Mar; 9(3):315-23. PubMed ID: 26634945
[TBL] [Abstract][Full Text] [Related]
5. [Novel targeted therapy in multiple myeloma].
Izumi T
Nihon Rinsho; 2014 Jun; 72(6):1089-93. PubMed ID: 25016809
[TBL] [Abstract][Full Text] [Related]
6. Resistance to proteasome inhibitors and other targeted therapies in myeloma.
Wallington-Beddoe CT; Sobieraj-Teague M; Kuss BJ; Pitson SM
Br J Haematol; 2018 Jul; 182(1):11-28. PubMed ID: 29676460
[TBL] [Abstract][Full Text] [Related]
7. The use of novel agents in multiple myeloma patients with hepatic impairment.
Stansfield LC; Gonsalves WI; Buadi FK
Future Oncol; 2015; 11(3):501-10. PubMed ID: 25675129
[TBL] [Abstract][Full Text] [Related]
8. New pharmacotherapy options for multiple myeloma.
Mina R; Cerrato C; Bernardini A; Aghemo E; Palumbo A
Expert Opin Pharmacother; 2016; 17(2):181-92. PubMed ID: 26684262
[TBL] [Abstract][Full Text] [Related]
9. Novel targeted therapies and combinations for the treatment of multiple myeloma.
Agarwal A; Mahadevan D
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):2-15. PubMed ID: 22882073
[TBL] [Abstract][Full Text] [Related]
10. Novel investigational drugs active as single agents in multiple myeloma.
D'Agostino M; Salvini M; Palumbo A; Larocca A; Gay F
Expert Opin Investig Drugs; 2017 Jun; 26(6):699-711. PubMed ID: 28448171
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies in monoclonal gammopathies.
Niesvizky R
Hematology; 2012 Apr; 17 Suppl 1():S121-4. PubMed ID: 22507798
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic avenues in myeloma: changing the treatment paradigm.
Ghobrial J; Ghobrial IM; Mitsiades C; Leleu X; Hatjiharissi E; Moreau AS; Roccaro A; Schlossman R; Hideshima T; Anderson KC; Richardson P
Oncology (Williston Park); 2007 Jun; 21(7):785-92; discussion 798-800. PubMed ID: 17722741
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms in multiple myeloma drug resistance.
Nikesitch N; Ling SC
J Clin Pathol; 2016 Feb; 69(2):97-101. PubMed ID: 26598624
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapies targeting the ubiquitin proteasome system in cancer.
Weathington NM; Mallampalli RK
J Clin Invest; 2014 Jan; 124(1):6-12. PubMed ID: 24382383
[TBL] [Abstract][Full Text] [Related]
15. Integration of novel agents into treatment of myeloma.
Lee AI; Munshi NC
Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S215-21. PubMed ID: 17877847
[TBL] [Abstract][Full Text] [Related]
16. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
Bianchi G; Anderson KC
CA Cancer J Clin; 2014; 64(6):422-44. PubMed ID: 25266555
[TBL] [Abstract][Full Text] [Related]
17. New Drugs in Multiple Myeloma.
Kunacheewa C; Orlowski RZ
Annu Rev Med; 2019 Jan; 70():521-547. PubMed ID: 30691369
[TBL] [Abstract][Full Text] [Related]
18. [New drugs in the treatment of multiple myeloma].
Oriol A; Motlló C
Med Clin (Barc); 2014 Sep; 143(6):268-74. PubMed ID: 24342015
[TBL] [Abstract][Full Text] [Related]
19. [Molecular targeting agents for multiple myeloma].
Fujii S; Abe M
Nihon Rinsho; 2012 Nov; 70 Suppl 8():518-23. PubMed ID: 23513894
[No Abstract] [Full Text] [Related]
20. Sequential or combination therapy for multiple myeloma.
Nooka A; Lonial S
Expert Rev Hematol; 2012 Oct; 5(5):533-45. PubMed ID: 23146057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
